1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsResearch Opportunities in Cancer Epidemiology Cohort Studies (PAR-27-073) is sponsored by National Cancer Institute (NCI). This funding opportunity focuses on cancer epidemiology cohort studies.
Get alerted about grants like this
Get emailed when new opportunities from “National Cancer Institute (NCI)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Agency: National Institutes of Health Assistance Listings: 93. 393 -- Cancer Cause and Prevention Research Last Updated: May 13, 2026 View version history on Grants.
gov Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort studies that address specific knowledge gaps in cancer etiology and survivorship.
Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and sharing of data and biospecimen resources as appropriate.
For-profit organizations other than small businesses Private institutions of higher education Public and state institutions of higher education Independent school districts Public and Indian housing authorities City or township governments Federally recognized Native American tribal governments Special district governments Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Other Native American tribal organizations Refer to Section III.
Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Grantor contact information Epidemiology and Genomics Research Program, NCI ncidccpsegrpnofos@mail. nih.
gov ncidccpsegrpnofos@mail. nih. gov ncidccpsegrpnofos@mail.
nih. gov File name Description Last updated PAR-27-073-Full-Announcement. html PAR-27-073-Full-Announcement.
html Link to additional information Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Contact program director by program's relevant areas of interest. (U01, Clinical Trial Not Allowed). Confirm the full requirements in the official notice before applying.
Applications for Research Opportunities in Cancer Epidemiology Cohort Studies (PAR-27-073) are due July 6, 2029. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Research Opportunities in Cancer Epidemiology Cohort Studies (PAR-27-073) is funded by National Cancer Institute (NCI). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On May 21, 2026, the National Cancer Institute posted RFA-CA-27-006, RFA-CA-27-007, and RFA-CA-27-008 — the three competitive renewals for the NCI Community Oncology Research Program. Combined FY 2027 commitments reach $147.5 million across roughly 57 awards: $74.5 million for up to 7 Research Bases, $73 million for up to 50 Community and Academic Community Sites. Pre-application webinars run June 16-18 this week. Applications are due August 18, 2026 with six-year project periods. For community hospitals, oncology consortia, and NCI-designated cancer centers, this is the single largest cancer clinical-trials infrastructure decision NCI makes until 2033.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article